Why the study?
A novel KCNH2 (hERG) variant associated with type 2 long QT syndrome (LQT2) required functional characterization because integrating genotype analysis into clinical evaluation facilitates more accurate diagnosis and targeted therapeutic strategies.
Does the novel KCNH2 c.1288G > C (p.A430P) variant impair hERG potassium channel function, protein expression, and mRNA abundance in HEK293 cells compared to wild-type KCNH2?
Does the novel KCNH2 c.1288G > C (p.A430P) variant impair hERG potassium channel function, protein expression, and mRNA abundance in HEK293 cells compared to wild-type KCNH2?
Identifies a novel pathogenic KCNH2 c.1288G>C (p.A430P) variant causing Type 2 Long QT Syndrome via complete loss of hERG channel current despite unchanged protein levels and elevated mRNA, suggesting post-transcriptional or translational dysregulation.
Answers are grounded in this paper and cite their sources.
Should not yet change LQT2 practice; leaves open post-transcriptional KCNH2 mechanisms for further study.
BACKGROUND: A novel variant in the KCNH2 gene (human ether-a-go-go-related gene, hERG) has been identified and is associated with type 2 long QT syndrome (LQT2). Integrating genotype analysis into clinical evaluation facilitates more accurate diagnosis and targeted therapeutic strategies for this condition. METHOD: Sanger sequencing was used to detect the KCNH2 variant in an LQT2 family. The variant was transiently expressed in HEK293 cells for functional characterization via patch-clamp electrophysiology, Western blot, and qRT-PCR. RESULT: A novel heterozygous missense variant KCNH2 c.1288G > C (p.Ala430Pro) was identified. Unlike wild-type (WT) channels, the A430P variant generated no detectable hERG currents. Western blot showed comparable protein expression between WT and A430P, both migrating at approximately 127 kDa, which corresponds to the core-glycosylated form. qRT-PCR revealed significantly elevated A430P mRNA levels compared to WT (p = 0.0027). CONCLUSION: The complete loss of channel function in the A430P variant is not due to reduced protein expression. The discordance between elevated mRNA and unchanged protein levels suggests post-transcriptional or translational dysregulation, expanding our understanding of LQT2 molecular mechanisms.
No takes yet. Share an insight, caveat, or question.
Hong et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: